# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-099226
Filing Date
2019-04-05
Accepted
2019-04-05 16:16:04
Documents
5
Period of Report
2019-05-16
Effectiveness Date
2019-04-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d647082ddef14a.htm | DEF 14A | 411929
2 | GRAPHIC | g647082g99b25.jpg | GRAPHIC | 8830
3 | GRAPHIC | g647082page002.jpg | GRAPHIC | 164233
4 | GRAPHIC | g647082page003.jpg | GRAPHIC | 204635
5 | GRAPHIC | g647082page004.jpg | GRAPHIC | 205467
| Complete submission text file | 0001193125-19-099226.txt |  | 1216688

Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36112 | Film No.: 19735315
SIC: 2834 Pharmaceutical Preparations